Agatroban treatment of cerebral infarction may work within 3 days, or it may be ineffective or even have bleeding side effects.
The drug is mainly used for the improvement of neurological symptoms (motor paralysis), daily activities (walking, getting up, maintaining sitting position, eating and drinking) in patients in the acute phase of ischemic cerebral infarction within 48 hours of the onset of the disease. It is used for the improvement of ulceration of the extremities, resting pain and coldness in patients with chronic arterial occlusive disease (thromboembolic vasculitis, occlusive atherosclerosis).
Agatroban has selective antithrombin, prolonging the clotting time effect, 30 minutes after the drug blood concentration can reach the peak, the half-life is short 15~30 minutes.
Patients with cerebral infarction are considered to be effective when their clinical symptoms are no longer progressing after using Argatroban and tend to be stabilized or when the original symptoms have improved. There are large individual differences, some of which can be effective within 3 days, while some of which can have no obvious effect, and even side effects such as hemorrhage can occur. This drug is prohibited for people with bleeding disorders; side effects such as allergy, gastrointestinal bleeding and cerebral hemorrhage may occur after use.
Patients with cerebral infarction should seek medical treatment in time and follow the doctor’s instructions; recovery from cerebral infarction is a long process, do not be in a hurry.